上海市锦天城（深圳）律师事务所 关于深圳市英可瑞科技股份有限公司 2025 年第一次临时股东大会的 法律意见书 上海市锦天城（深圳）律师事务所 法律意见书 上海市锦天城（深圳）律师事务所 关于深圳市英可瑞科技股份有限公司 2025 年第一次临时股东大会的 法律意见书 致：深圳市英可瑞科技股份有限公司 上海市锦天城（深圳）律师事务所（以下简称"本所"）接受深圳市英可瑞科 技股份有限公司（以下简称"公司"）委托，就公司召开 2025 年第一次临时股东 大会（以下简称"本次股东大会"）的有关事宜，根据《中华人民共和国公司法》 （以下简称《公司法》）《上市公司股东会规则》等法律、法规、规章和其他规范 性文件以及《深圳市英可瑞科技股份有限公司章程》（以下简称《公司章程》）的 有关规定，出具本法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则（试行）》等规定，严格履行 了法定职责，遵循了勤勉尽责和诚实信用原则，对本次股东大会所涉及的相关事 项进行了必要的核查和验证，核查了本所认为出具该法律意见书所需的相关文件、 资料，并参加了公司本次股东大会的全 ...

证券代码：300713 证券简称：英可瑞 公告编号：2025-039 深圳市英可瑞科技股份有限公司 2025年第一次临时股东大会决议公告 （2）网络投票：通过深圳证券交易所交易系统进行网络投票的具体时间为 2025年9月12日上午9:15—9:25，9:30—11:30，下午13:00—15:00；通过深圳证 券交易所互联网投票的具体时间为：2025年9月12日上午9:15至下午15:00期间的 任意时间。 3.会议地点：深圳市南山区中山园路1001号国际E城E1栋11楼公司大会议室。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1.本次股东大会无增加、变更、否决议案的情形。 2.本次股东大会未涉及变更前次股东大会决议情况。 一、会议召开和出席情况 1.股东大会届次：2025年第一次临时股东大会 2.会议召开的日期、时间： （1）现场会议召开：2025年9月12日下午14:30时开始 4.会议召开方式：本次股东大会采用现场表决与网络投票相结合的方式。 5.股东大会的召集人：本次股东大会的召集人为董事会。 6.会议主持人：公司董事长尹伟先生。 7 ...

Group 1 - The core viewpoint of the news is that Shenzhen Inke Rui Technology Co., Ltd. is actively engaging with investors and showcasing its business performance and future plans, particularly in the electric vehicle charging and power supply sectors [1][2]. - In the first half of 2025, the revenue from electric vehicle charging power products reached 103 million yuan, representing a year-on-year growth of 91.05%. The revenue from power operation products was 20.11 million yuan, with a slight increase of 0.30%, while other power products generated 74.21 million yuan, marking a growth of 77.36% [1]. - The company emphasizes technological innovation to enhance product competitiveness and market expansion, although it has not confirmed profitability for the current year [1][2]. Group 2 - The overseas business layout shows that in the first half of 2025, the company's subsidiary achieved a revenue of 23.21 million yuan and a net profit of 5.45 million yuan, indicating a focus on international markets and tailored product development [2]. - The HVDC power supply and system are primarily used in data center rooms, with the HVDC power module utilizing air cooling technology [2]. - The company is committed to long-term incentive mechanisms and will consider various factors for any future plans, ensuring compliance with regulatory procedures and timely disclosures [2].

Core Viewpoint - Yingkerui (SZ 300713) announced a scheduled investor meeting on September 9, 2025, where key executives will address investor inquiries [1] Group 1: Company Overview - Yingkerui's revenue composition for the year 2024 is as follows: 56.35% from the new energy vehicle industry, 26.17% from other power sources, and 17.48% from the power industry [1] - As of the report, Yingkerui has a market capitalization of 2.9 billion yuan [1]

Group 1: Business Performance - In the first half of 2025, the company's revenue from electric vehicle charging power products reached ¥103,039,732.65, a year-on-year increase of 91.05% [2] - Revenue from electric power operation products was ¥20,105,518.20, with a slight year-on-year growth of 0.30% [2] - Other power products generated revenue of ¥74,212,606.30, reflecting a year-on-year increase of 77.36% [2] Group 2: Market Strategy - The company aims to enhance product competitiveness and market expansion by driving technological innovation [2] - Plans to optimize and integrate resources to support core business development and improve operational management strategies [3] Group 3: International Business Development - The company's subsidiary, Shenzhen Yingkerui International Holdings Co., Ltd., achieved revenue of ¥23,205,729.95 and a net profit of ¥5,452,348.36 in the first half of 2025 [4] - The company is focused on overseas market development, targeting product research and development to meet diverse customer needs [4] Group 4: Product Development - The HVDC power supply and systems are primarily used in data center facilities, with current products utilizing air cooling technology [5] Group 5: Employee Incentives - The company emphasizes the establishment of long-term incentive mechanisms, including potential stock options, to foster mutual growth with employees [6] Group 6: Information Disclosure - The company ensured that the investor relations activity did not involve any undisclosed significant information [7]

Group 1 - The company, InnoCare Pharma (英可瑞), reported that as of August 29, 2025, the total number of shareholders is approximately 14,500 [1]

Core Viewpoint - The financial report of Yingkerui (300713) for the first half of 2025 shows significant revenue growth but continued net losses, indicating potential challenges in profitability despite increased sales [1]. Financial Performance Summary - Total revenue for the first half of 2025 reached 197 million yuan, a year-on-year increase of 66.77% compared to 118 million yuan in the same period of 2024 [1]. - The net profit attributable to shareholders was -25.81 million yuan, improving by 11.20% from -29.06 million yuan in the previous year [1]. - The gross margin increased to 21.52%, up by 4.96% from 20.50% in 2024, while the net margin improved to -14.30%, a 49.69% increase from -28.42% [1]. - The total of selling, administrative, and financial expenses was 39.49 million yuan, accounting for 20.01% of revenue, a decrease of 21.07% year-on-year [1]. - The company's cash flow from operating activities showed a significant decline of 259.53%, attributed to increased payments to employees [3][5]. Balance Sheet Changes - Inventory increased by 58.68%, indicating a buildup of stock likely due to new product development and existing orders [1][4]. - Accounts receivable rose by 10.85% to 201 million yuan, reflecting increased sales [1][4]. - Interest-bearing liabilities increased by 35.81% to 140 million yuan, indicating higher debt levels [1]. - Cash and cash equivalents decreased by 43.50% to 45.86 million yuan, highlighting liquidity concerns [1]. Cash Flow Analysis - The net cash flow from financing activities decreased by 81.95%, primarily due to reduced bank borrowings [5]. - The net increase in cash and cash equivalents dropped by 247.35%, driven by higher employee payments and decreased borrowings [5]. Operational Insights - The increase in sales expenses by 25.78% and administrative expenses by 37.44% suggests rising operational costs, potentially impacting future profitability [4]. - The company has experienced a historical average return on invested capital (ROIC) of 1.48%, with a notably poor ROIC of -13.36% in 2024, indicating challenges in generating returns on investments [5].

Financial Performance - The company reported a total revenue of 197 million yuan for the first half of 2025, representing a year-on-year increase of 66.77% [1] - The net profit attributable to shareholders was -25.81 million yuan, an improvement of 11.2% compared to the previous year [1] - The gross margin increased to 21.52%, up by 4.96% year-on-year, while the net margin improved to -14.3%, a 49.69% increase [1] - The total of selling, administrative, and financial expenses was 39.49 million yuan, accounting for 20.01% of revenue, a decrease of 21.07% year-on-year [1] Balance Sheet Highlights - Inventory saw a significant increase of 58.68% year-on-year, indicating a buildup in stock [1] - Cash and cash equivalents decreased by 43.50% to 45.86 million yuan [3] - Accounts receivable rose by 10.85% to 201 million yuan, attributed to increased sales [3] - Interest-bearing debt increased by 35.81% to 140 million yuan [1] Cash Flow Analysis - Operating cash flow per share was -0.08 yuan, a decline of 259.53% year-on-year, indicating cash outflows [1][3] - The net cash flow from operating activities decreased significantly due to higher payments to employees [3] - The net cash flow from investing activities improved by 43.48%, reflecting reduced cash outflows for fixed and intangible asset purchases [3] Operational Insights - The increase in revenue was driven by a higher order volume, with operating income rising by 66.77% [3] - The company faced challenges with cash flow management, as indicated by the negative operating cash flow and the low ratio of cash to current liabilities at 28.4% [5] - Historical data shows a median Return on Invested Capital (ROIC) of 1.48%, with a particularly poor performance in 2024 at -13.36% [4]

Core Viewpoint - In the semi-annual report for 2025, Yingkerui (300713.SZ) disclosed that institutional investors hold a total of 5.9886 million shares, representing 3.77% of the company's total equity, indicating a decrease in institutional ownership compared to the previous quarter [1] Institutional Ownership - As of August 25, 2025, three institutional investors have disclosed their holdings in Yingkerui A-shares, with a combined ownership of 5.9886 million shares [1] - The total institutional ownership percentage has decreased by 1.17 percentage points compared to the previous quarter [1] Foreign Investment - Two foreign funds, BARCLAYS BANK PLC and UBS AG, have increased their holdings in Yingkerui, contributing to a slight rise in foreign ownership [1] - Notably, J.P. Morgan Securities PLC and Goldman Sachs LLC have not disclosed their holdings in this period, indicating a potential shift in foreign investment dynamics [1]

Core Viewpoint - Inke Rui (300713) announced that it will hold its first extraordinary general meeting of shareholders in 2025 on September 12, 2025, to review multiple proposals including amendments to the company's articles of association and governance systems [1] Group 1 - The extraordinary general meeting is scheduled for September 12, 2025 [1] - The agenda includes the proposal to amend the company's articles of association [1] - Additional governance system proposals will also be reviewed during the meeting [1]